Terminated PHASE3 INTERVENTIONAL 2-arm NCT01184443

Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents

Evaluation of the Efficacy and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Children and Adolescents: An Open-label Trial

Sponsor: Children's Hospital of Eastern Ontario

Conditions Eating Disorder

Interventions Olanzapine

Updated 5 times since 2017 Last updated: Sep 3, 2014 Started: Aug 31, 2010 Primary completion: Aug 31, 2013 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor recruitment

Other terminated trials from Children's Hospital of Eastern Ontario

See all terminations from Children's Hospital of Eastern Ontario

A PHASE3 clinical study on Eating Disorder, this trial is terminated or withdrawn. The trial is conducted by Children's Hospital of Eastern Ontario and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Hospital of Eastern Ontario

Data source: Children's Hospital of Eastern Ontario

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottawa, Canada